Coronavirus outbreak

[-NucksFan]

7 hours ago, Silky mitts said:

Rumours gyms reopen May 19?

I heard likely mid June , know someone who works at Club 16 , still trying to figure out how it will work 

[JoeyJoeJoeJr. Shabadoo]

2 hours ago, stawns said:

That's the justification were being told.  Though I think it's a terrible, dangerous move and I am not happy about having to spend a month in a building with 200 people, I do miss the kids terribly.

That's what I don't get. We are only supposed to open up our bubble to one family yet teachers and students will be opening up their bubbles to 200 plus? Some high schools have over 2000 students and staff. Seems like a recipe for disaster.

[kingofsurrey]

30 minutes ago, JoeyJoeJoeJr. Shabadoo said:

That's what I don't get. We are only supposed to open up our bubble to one family yet teachers and students will be opening up their bubbles to 200 plus? Some high schools have over 2000 students and staff. Seems like a recipe for disaster.

Very disappointed with our Premier and Dr. Bonnie today.

 

Selling out our senior citizens so  kids can go back to some form of school for 8 days in june.   This will look nothing like regular school for the kids.

How many seniors will now be infected due to kids infecting kids/teachers ?

 

So pointless.   Listening to the politicians skirt around the questions today was depressing.  At the end of the day, the premier said basically individual school districts will have to figure it out.  Such a lack of leadership in BC. 

[CBH1926]

Trillions are flying like mosquitoes, another round of payments as well as continuing paying extra money through January for the unemployed. Goobers are complaining of course and will block it.

Some folks are making more money staying home than going to work!

https://www.cnn.com/2020/05/15/politics/house-vote-covid-aid-3-trillion-remote-voting/index.html

Edited May 16, 2020 by CBH1926

[Warhippy]

4 hours ago, goalie13 said:

Second reason:  Test run for September.

Spoke to my daughters principal today and that's exactly what he said.  A dry run for september in a worst case scenario

[kingofsurrey]

19 minutes ago, Warhippy said:

Spoke to my daughters principal today and that's exactly what he said.  A dry run for september in a worst case scenario

BC has done an amazing job the last 2 months.

 

Makes no sense to risk it all so elementary kids can attend 8 days in June and highschool kids can attend 4 days in June.

 

Outbreak now at Abbotsford Regional Hospital......

Edited May 16, 2020 by kingofsurrey

[The Aquamen]

Sign Nikita Tryamkin.

 

also, Visliy Podkolzin is coming next year, NHL ready. 
 

Judd Brackett? I trust Jim Benning. 

 

Please don’t resign Toffoli for more than 3-4 years per 5 million. Sign Jacob and Nikita. Let Leivo walk, try and trade Sutter.

 

Edited May 16, 2020 by The Aquamen

[Me_]

On 5/16/2020 at 12:28 AM, The Aquamen said:

Sign Nikita Tryamkin.

 

also, Visliy Podkolzin is coming next year, NHL ready. 
 

Judd Brackett? I trust Jim Benning. 

 

Please don’t resign Toffoli for more than 3-4 years per 5 million. Sign Jacob and Nikita. Let Leivo walk, try and trade Sutter.

 

Sounds like you took a wrong turn bud...

 

Canucks stuff is the other way.

 

Edited May 17, 2020 by Me_

[spur1]

26 minutes ago, The Aquamen said:

Sign Nikita Tryamkin.

 

also, Visliy Podkolzin is coming next year, NHL ready. 
 

Judd Brackett? I trust Jim Benning. 

 

Please don’t resign Toffoli for more than 3-4 years per 5 million. Sign Jacob and Nikita. Let Leivo walk, try and trade Sutter.

 

Why has he got his shirt on? 

[kingofsurrey]

This one made me laugh... only in Bc...

 

 

Student: Now that some of us are back, sir, what will we be doing that's different from the online students?

Teacher: Not much. We'll be examing the online resources in more detail.

S: So I could just stay home?

T: Yes.

S: So why am I here?

T: Good question

Edited May 16, 2020 by kingofsurrey

[stawns]

1 hour ago, JoeyJoeJoeJr. Shabadoo said:

That's what I don't get. We are only supposed to open up our bubble to one family yet teachers and students will be opening up their bubbles to 200 plus? Some high schools have over 2000 students and staff. Seems like a recipe for disaster.

Yup, no argument here.  

 

K-5 are split into two groups, coming on alternating days, with Fridays for distance learning.

 

6-12 will come one day a week and the rest is distance learning.  That's my understanding of what my district is telling me.  So, in my school, you're looking at 200-250 people in building on any given day.

 

The caveat, of course, is that is if every parent sends their kid and we know that won't happen.  I expect it'll be far lower than that.  Still, it's a dangerous experiment at this point, imo.

[Elias Pettersson]

https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19

 

NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19

Study enrolling adults with mild to moderate COVID-19 in the United States.

 

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial, which is being conducted by the NIAID-funded AIDS Clinical Trials Group (ACTG). Teva Pharmaceuticals is donating medications for the study.

 

The Phase 2b trial will enroll approximately 2,000 adults at participating ACTG sites(link is external) across the United States. Study participants must have confirmed infection with SARS-CoV-2, the virus that causes COVID-19, and be experiencing fever, cough and/or shortness of breath. The investigators anticipate that many of those enrolled will be 60 years of age or older or have a comorbidity associated with developing serious complications from COVID-19, such as cardiovascular disease or diabetes. Participants will be randomly assigned to receive short-term treatment with either hydroxychloroquine and azithromycin or matching placebos. People living with HIV and pregnant and breastfeeding women also are eligible to participate in the study. The first participant enrolled today in San Diego, California.

 

“We urgently need a safe and effective treatment for COVID-19. Repurposing existing drugs is an attractive option because these medications have undergone extensive testing, allowing them to move quickly into clinical trials and accelerating their potential approval for COVID-19 treatment,” said NIAID Director Anthony S. Fauci, M.D. “Although there is anecdotal evidence that hydroxychloroquine and azithromycin may benefit people with COVID-19, we need solid data from a large randomized, controlled clinical trial to determine whether this experimental treatment is safe and can improve clinical outcomes.”

 

As of May 13, the World Health Organization (WHO)(link is external) has reported 4.17 million cases of and 287,399 deaths from COVID-19 worldwide. In the United States, 1.36 million confirmed COVID-19 cases and 82,246 deaths have been reported as of May 13, according to the Centers for Disease Control and Prevention (CDC)(link is external).

 

Currently, there are no specific therapeutics approved by the U.S. Food and Drug Administration to treat people with COVID-19. Hydroxychloroquine is FDA-approved to prevent and treat malaria, as well as to treat the autoimmune diseases rheumatoid arthritis and lupus. Some preliminary reports have suggested that hydroxychloroquine, alone or in combination with the FDA-approved antibiotic azithromycin, may benefit people with COVID-19. Numerous clinical trials are planned or underway, including a recently launched study supported by NIH’s National Heart, Lung and Blood Institute evaluating the safety and effectiveness of hydroxychloroquine for treatment of adults hospitalized with COVID-19. On March 28, FDA issued an Emergency Use Authorization(link is external) (EUA) to allow hydroxychloroquine and medical-grade chloroquine to be distributed from the Strategic National Stockpile and prescribed by doctors to hospitalized adolescents and adults with COVID-19, as appropriate, when a clinical trial is not available or feasible. 

 

Participants will record their symptoms, adherence to treatment, and major events such as hospitalizations in a diary for 20 days. Study staff will follow up with participants by telephone during this period. When possible, participants will come to the clinical research site for an in-person visit at day 20. Additional follow-ups will be conducted by telephone three and six months after treatment starts.

 

The main objective of the study is to determine whether hydroxychloroquine and azithromycin can prevent hospitalization and death due to COVID-19. Additionally, investigators will evaluate the safety and tolerability of the experimental treatment for people with SARS-CoV-2 infection. While hydroxychloroquine and azithromycin are both considered safe in most people, they can cause side effects ranging from headache and nausea to, rarely, heart rhythm problems that can be life-threatening. Because of the risk of heart problems when hydroxychloroquine is used alone or combined with azithromycin, FDA cautions that use of hydroxychloroquine for COVID-19 should be limited to clinical trials or for treating certain hospitalized patients under EUA(link is external) so clinicians can monitor patients for adverse effects.

 

“This study will provide key data to aid responses to the COVID-19 pandemic,” said ACTG Chair Judith Currier, M.D., of the University of California, Los Angeles. “We are pleased to be able to leverage ACTG’s existing infrastructure for HIV treatment clinical trials to quickly implement this important study.”

 

The study team is led by Protocol Chair Davey Smith, M.D., of the University of California, San Diego. David Wohl, M.D., of the University of North Carolina at Chapel Hill, and Kara W. Chew, M.D., and Eric S. Daar, M.D., both of the University of California, Los Angeles, serve as protocol vice-chairs. The trial is expected to enroll quickly given the high incidence of COVID-19, and initial results may be available later this year.

 

[The Aquamen]

45 minutes ago, spur1 said:

Why has he got his shirt on? 

It looks very cold there. 
 

[Elias Pettersson]

https://www.worldhealth.net/news/cedars-sinai-use-uv-light-treat-covid-19

 

Cedars-Sinai To Use UV Light To Treat COVID-19

 

Ultraviolet therapy may be coming to a hospital near you to help treat COVID-19 developed by Cedars-Sinai hospital in Los Angeles. 

Healight Platform Technology has been exclusively licensed to Aytu BioScience Inc for worldwide commercial development and release which could mean that hospitals around the globe may soon adopt this approach.

According to some reports this method has been billed as being a potential “first-in-class treatment for coronavirus and other respiratory infections,”  that utilizes proprietary methods of administering intermittent UVA light using a novel endotracheal device. Preclinical study findings are suggesting that this approach has the potential to help eradicate the spread of this COVID-19 outbreak, as well as “a wide range of viruses and bacteria, inclusive of coronavirus.”

A team from the Medically Associated Science and Technology Program at Cedars-Sinai led by Dr. Mark Pimental, MD have been developing Healight since 2016, and it has a growing body of evidence demonstrating its efficacy as both an antiviral and an antibacterial treatment. 

There have been rumors of talks with the FDA about the development of a near term path that could enable early use of this technology to help the COVID-19 patients who are suffering in ICUs, and it may also be useful in treating ventilator associated pneumonia, or VAP. 

"Our team has shown that administering a specific spectrum of UV-A light can eradicate viruses in infected human cells (including coronavirus) and bacteria in the area while preserving healthy cells," stated Dr. Pimentel of Cedars-Sinai. Ali Rezaie, MD, one of the inventors of this technology states, "Our lab at Cedars-Sinai has extensively studied the effects of this unique technology on bacteria and viruses. Based on our findings we believe this therapeutic approach has the potential to significantly impact the high morbidity and mortality of coronavirus-infected patients and patients infected with other respiratory pathogens. We are looking forward to partnering with Aytu BioScience to move this technology forward for the benefit of patients all over the world."

The FDA, Aytu, and Cedars-Sinai are rumored to be working together towards developing a plan for the expedited regulatory approval of Healight to be used against the continued battle against the global COVID-19 outbreak. Those critical ill with this virus may benefit from use of this minimally invasive treatment approach.

Around the globe many hospitals are already using UV light to help clean surfaces and disinfect rooms where COVID-19 patients have been treated, extending the use of such technology to the direct treatment of the virus in patients would appear to be the next logical step. 

Natural UV light from the sun appears to be able to destroy most harmful bacteria on the skin as well as viruses and other microbes, similar benefit could also potentially be gained from using artificial UV rays generated by medical devices, and this is what Aytu and Cedars-Sinai are hoping will be widely implemented around the globe. 

“We are honored to be partnering with Cedars-Sinai as we believe the Healight therapeutic platform has the potential to help many patients during this coronavirus pandemic and beyond.This first-in-class technology has the potential to be a game changer for clinicians treating patients infected with coronavirus and other respiratory conditions, and our team is working tirelessly alongside the Cedars-Sinai team to determine the safety and effectiveness of this device in humans,” says Josh Disbrow, Chairman and CEO of Aytu BioScience.

[Elias Pettersson]

https://news.columbia.edu/ultraviolet-technology-virus-covid-19-UV-light

 

Could a New Ultraviolet Technology Fight the Spread of Coronavirus?

Columbia researcher David Brenner believes far-UVC light—safe for humans, but lethal for viruses—could be a ‘game changer.’

 

A technique that zaps airborne viruses with a narrow-wavelength band of UV light shows promise for curtailing the person-to-person spread of COVID-19 in indoor public places.

 

The technology, developed by Columbia University’s Center for Radiological Research, uses lamps that emit continuous, low doses of a particular wavelength of ultraviolet light, known as far-UVC, which can kill viruses and bacteria without harming human skin, eyes and other tissues, as is the problem with conventional UV light.

 

“Far-UVC light has the potential to be a ‘game changer,’” said David Brenner, professor of radiation biophysics and director of the center. “It can be safely used in occupied public spaces, and it kills pathogens in the air before we can breathe them in.”

 

The research team's experiments have shown far-UVC effective in eradicating two types of airborne seasonal coronaviruses (the ones that cause coughs and colds). The researchers are now testing the light against the SARS-CoV-2 virus in collaboration with Thomas Briese and W. Ian Lipkin of the Center for Infection and Immunity in a biosafety laboratory on Columbia's medical center campus, with encouraging results, Brenner said. 

 

The team previously found the method effective in inactivating the airborne H1N1 influenza virus, as well as drug-resistant bacteria. And multiple, long-term studies on animals and humans have confirmed that exposure to far-UVC does not cause damage to the skin or eyes.

 

"Our system is a low-cost, safe solution to eradicating airborne viruses minutes after they've been breathed, coughed or sneezed into the air."

 

If widely used in occupied public places, far-UVC technology has the potential to provide a powerful check on future epidemics and pandemics, Brenner said. He added that even when researchers develop a vaccine against the virus that causes COVID, it will not protect against the next novel virus.

 

“Our system is a low-cost, safe solution to eradicating airborne viruses minutes after they've been breathed, coughed or sneezed into the air,” Brenner said. “Not only does it have the potential to prevent the global spread of the virus that causes COVID-19, but also future novel viruses, as well as more familiar viruses like influenza and measles.”

 

Brenner envisions the use of safe overhead far-UVC lamps in a wide range of indoor public spaces. The technology, which can be easily retrofitted into existing light fixtures, he said, could be deployed in hospitals and doctors’ offices as well as schools, shelters, airports, airplanes and other transportation hubs.

 

Scientists have known for decades that germicidal UV light (wavelength around 254 nm) has the capacity to kill viruses and bacteria. Hospitals and laboratories often use germicidal UV light to sterilize unoccupied rooms, as well as other equipment. But conventional germicidal UV light cannot be used in the presence of people as it can causes health problems to the skin and eyes.

 

In contrast, far-UVC light, which has a very short wavelength (in the range from about 205 to 230 nm), cannot reach or damage living human cells. But these wavelengths can still penetrate and kill very small viruses and bacteria floating in the air or on surfaces.

 

Far-UVC lamps are now in production by several companies, although ramping up to large-scale production, as well as approval by the Food and Drug Administration and Environmental Protection Agency, will take several months. At between $500 and $1000 per lamp, the lamps are relatively inexpensive, and once they are mass produced the prices would likely fall, Brenner said.

 

“Far-UVC takes a fundamentally different tactic in the war against COVID-19,” Brenner said. “Most approaches focus on fighting the virus once it has gotten into the body. Far-UVC is one of the very few approaches that has the potential to prevent the spread of viruses before they enter the body.”

[filthycanuck]

9 hours ago, greenbean said:

Yep. I'm pretty disappointed in what BC is opening up so quickly.

There should be no way Gyms or schools should be opening this quickly. We should be opening retail and medical services and see how that goes. They are the least risky things to open.

Seems like we are opening up stuff that is super risky way too quickly and it could be very bad.

I agree, this 1st phase is really to see how we can function with some restrictions being lifted, we can wait for schools, gyms all that stuff for July

[Gawdzukes]

10 hours ago, The Aquamen said:

Sign Nikita Tryamkin.

 

also, Visliy Podkolzin is coming next year, NHL ready. 
 

Judd Brackett? I trust Jim Benning. 

 

Please don’t resign Toffoli for more than 3-4 years per 5 million. Sign Jacob and Nikita. Let Leivo walk, try and trade Sutter.

 

Tryamkin is a baby. No thanks.

[-DLC-]

23 hours ago, skategal said:

There are cloth masks for sale online or if you are lucky a friend that sews has taken up the cause and is making them for all their friends.  A golf buddy said she bought a box of masks at London Drugs, so probably like disinfectant wipes, it's all in the timing!  

I saw the at London Drug (50 for $49.99) and kicked myself for not getting them.  Money's tight so didn't.

 

But was in Shopper's yesterday and they had them.  Same standard disposable ones (although, was ticked because the box showed a much different design..wasn't what was inside).  Got 50 for $43.99.

[JM_]

7 hours ago, Elias Pettersson said:

https://www.worldhealth.net/news/cedars-sinai-use-uv-light-treat-covid-19

7 hours ago, Elias Pettersson said:

https://news.columbia.edu/ultraviolet-technology-virus-covid-19-UV-light

 

 

these studies are interesting, but neither of them are going to be ready before a vaccine is, particularly the one using an endoscope to try to treat peoples lungs. 

[-DLC-]

https://www.forbes.com/sites/brucelee/2020/05/14/here-is-more-evidence-for-face-mask-use-with-covid-19-coronavirus/?utm_campaign=forbes&utm_source=facebook&utm_medium=social&utm_term=Valerie%2F&fbclid=IwAR1gtOlNvXokly_4uuOJhW_OVee7KOxq5AIL3FGT-oPnHJXWJIasfNyv4Ow#92a96461060b

 

Quote

Tired Of Wearing A Face Mask In Public? New Research Underscores Why You Still Need To

Bruce Y. LeeSenior Contributor

Healthcare

I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always in that order.

Arnold Schwarzenegger, seen here on a bicycle, has been participating in the #MaskingForAFriend ... [+]

 GC IMAGES

Should you cover it while out in the grocery store?

For some body parts, the answer has long been yes. Please, yes. However, when it comes to covering your face in public with the COVID-19 coronavirus continuing to spread, you may have been hearing some conflicting advice. Well, that’s in part because new scientific evidence about this nasty virus continues to emerge, like a study just published in the Proceedings of the National Academy of Sciences (PNAS). It’s also because the wearing of masks has become, get ready for this, politicized. Yes, politicized. The look of shock on your face from this revelation may be obvious, unless, of course, it is covered by a mask.

Well, let’s stick to the science. This PNAS study may provide more.....